openPR Logo
Press release

Rabies Veterinary Vaccines Market Envisaged To Reach USD 890.46 Million by 2032, With a CAGR of 4.2% from 2023 - 2032

06-14-2024 09:36 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Rabies Veterinary Vaccines Market

Rabies Veterinary Vaccines Market

Rabies is caused by viruses in the genus Lyssavirus. Effectively, all mammals are vulnerable to rabies contamination involving domestic animals as well as wild beastly repository populations where countless rabies virus alternatives are preserved. Dogs that have experienced a bite from an unrevealed or unvaccinated should be instantly vaccinated or segregated as approved. Vaccines energize adjustable immunity, which is antigen-reliant and antigen-particular. Thus, rabies vaccination offers safeguarding, particularly from rabies contamination. Numerous vaccines are permitted for usage in domestic animals, and disabled vaccines are obtainable for usage in dogs.

๐Š๐ž๐ฒ ๐’๐ญ๐š๐ญ๐ฌ

โ€ข The global rabies veterinary vaccines market was valued at USD 589.27 million in 2022.
โ€ข The industry is expected to grow at a CAGR of 4.2% during the forecast period.
โ€ข By 2032, the market is expected to reach USD 890.46 million.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ : https://www.polarismarketresearch.com/industry-analysis/rabies-veterinary-vaccines-market/request-for-sample

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ
Escalating consciousness about zoonotic illnesses, uninterrupted advancement of veterinary vaccines, and insurance scope for rabies vaccination push the market for rabies veterinary vaccines during the forecast period. Additionally, growing government inventiveness to subdue the virus, growing creature rabies extermination bait endeavors, a multitude of dog vaccination crusades, and notably growing pet possession rates in advancing countries push the rabies veterinary vaccines market.
The growing cases of rabies contamination in people emanating from domestic dogs or other wild creatures or by proximate confrontation with them when marching or camping have contributed to market augmentation.

๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐€๐๐จ๐ฉ๐ญ๐ž๐ ๐›๐ฒ ๐‹๐ž๐š๐๐ข๐ง๐  ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ

The market is equitably aggressive with the existence of many big and small players. Big firms are overtly traded and possess manifold portfolios with strong R&D, issuance, and sales potential. A list of key companies in the rabies veterinary vaccines market profiled are:
โ€ข Merck & Co. (MSD Animal Health)
โ€ข Indian Immunologicals Ltd
โ€ข Novartis AG
โ€ข Pfizer Inc
โ€ข Sanofi SA
โ€ข Boehringer Ingelheim International GmbH (Animal Health)
โ€ข BroadChem Philippines Biopharma Corporation
โ€ข Berna Biotech Ltd
โ€ข Elanco
โ€ข Ceva
โ€ข BiogรฉnesisBagรณ
โ€ข Bharat Biotech
โ€ข GlaxoSmithKline plc

๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/buy/1904/2

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ
โ€ข In 2022, the North American region held a dominant position in the global market due to the prevalence of an extensive pet population, which caused escalated healthcare veterinary prices.
โ€ข Asia Pacific is anticipated to develop at the quickest rate in the market over the forecast period due to nations such as China and India having canine rabies endemic with extensively more rabies-connected cases each year.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง
๐˜ฝ๐™ฎ ๐˜ผ๐™ฅ๐™ฅ๐™ก๐™ž๐™˜๐™–๐™ฉ๐™ž๐™ค๐™ฃ :
โ€ข Companion Animals
โ€ข Livestock Animals
โ€ข Wildlife Animals

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐€๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ : https://www.polarismarketresearch.com/industry-analysis/rabies-veterinary-vaccines-market

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:
๐™€๐™ญ๐™ค๐™จ๐™ค๐™ข๐™š ๐™๐™š๐™จ๐™š๐™–๐™ง๐™˜๐™ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/exosome-research-market
๐˜ฟ๐™ž๐™จ๐™ฅ๐™ค๐™จ๐™–๐™—๐™ก๐™š ๐™ˆ๐™š๐™™๐™ž๐™˜๐™–๐™ก ๐™Ž๐™š๐™ฃ๐™จ๐™ค๐™ง๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/disposable-medical-sensors-market
๐™Š๐™ฅ๐™๐™ฉ๐™๐™–๐™ก๐™ข๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/ophthalmic-drug-market
๐™Ž๐™–๐™ฉ๐™š๐™ก๐™ก๐™ž๐™ฉ๐™š ๐™„๐™ฃ๐™ฉ๐™š๐™ง๐™ฃ๐™š๐™ฉ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/satellite-internet-market
๐™ˆ๐™ค๐™ช๐™ฉ๐™ ๐™๐™ก๐™˜๐™š๐™ง ๐™๐™ง๐™š๐™–๐™ฉ๐™ข๐™š๐™ฃ๐™ฉ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/mouth-ulcer-treatment-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rabies Veterinary Vaccines Market Envisaged To Reach USD 890.46 Million by 2032, With a CAGR of 4.2% from 2023 - 2032 here

News-ID: 3538991 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โ€ฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโ€ฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โ€ฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected toโ€ฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โ€ฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโ€ฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โ€ฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโ€ฆ

All 5 Releases


More Releases for Rabies

Rabies Antiserum Market Growing with Global Rabies Prevention Efforts and Emerge โ€ฆ
Rabies Antiserum Market is estimated to be valued at USD 1.32 Bn in 2025 and is expected to reach USD 1.66 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 3.3% from 2025 to 2032. The qualitative latest Research report (2025-2032) on the Rabies Antiserum Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size,โ€ฆ
Key Trends Influencing the Growth of the Rabies Diagnostics Market in 2025: Prod โ€ฆ
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Is the Expected CAGR for the Rabies Diagnostics Market Through 2025? The market size for rabies diagnostics has seen significant growth in recent years. The market, which was worth $1.68 billion in 2024, is anticipated to expand to $1.78 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.6%. Factors suchโ€ฆ
Top Factor Driving Rabies Diagnostics Market Growth in 2025: Increasing Prevalen โ€ฆ
What market dynamics are playing a key role in accelerating the growth of the rabies diagnostics market? The market for rabies diagnostics is likely to be propelled by the escalating incidence of rabies. Rabies, a viral disease that can be prevented, is typically transmitted through a bite from an infected animal. It targets the central nervous system of mammals, leading to brain damage and eventual death. Various diagnostic tests and methodsโ€ฆ
Rabies Diagnostics Market is Driven by High Prevalence of Rabies in the World
Global Rabies Diagnostics Market: Overview Neglected tropical diseases have usually plagued densely populated areas with low resource availability across the globe. Rabies is one such neglected tropical disease that has always troubled animal and human population, especially in the African and Asian countries. The global rabies diagnostics market is likely to gather momentum from such high prevalence of rabies in these parts of the world. Read Report Overview - https://www.transparencymarketresearch.com/rabies-diagnostics-market.html Global Rabies Diagnosticsโ€ฆ
Rabies Treatment Market 2017 | Sanofi, GlaxoSmithKline, Cadila Healthcare
Global Rabies Treatment Market: Snapshot Earlier, widespread culling of animals was embarked upon to stamp out rabies โ€“ a fatal disease caused by rabies virus transmitted from animals to humans. Domestic dogs are mainly the carriers of the virus and over 95.0% of human deaths result from dog-mediated rabies, states WHO. It also finds that Asia and Africa account for almost 95.0% of the tens of thousands of rabies deaths occurringโ€ฆ
Rabies Vaccine Market Report 2018: Segmentation by Product (Vero Cell Rabies Vac โ€ฆ
Global Rabies Vaccine market research report provides company profile for Novartis Vaccines and Diagnostics Ltd., Cadila Pharmaceuticals Ltd., GlaxoSmithKline Biologicals, Merck & Co Inc., Wyeth pharmaceuticals, Berna Biotech Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the yearโ€ฆ